These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [How to treat locally advanced and metastatic untreated cancer of the prostate?]. Khoury S Prog Urol; 1996 Apr; 6(2 Suppl 1):42-5. PubMed ID: 8704744 [No Abstract] [Full Text] [Related]
10. Amphoterin induction in prostatic stromal cells by androgen deprivation is associated with metastatic prostate cancer. Kuniyasu H; Chihara Y; Kondo H; Ohmori H; Ukai R Oncol Rep; 2003; 10(6):1863-8. PubMed ID: 14534709 [TBL] [Abstract][Full Text] [Related]
11. The prognostic role of the pathological T2 subclassification for prostate cancer in the 2002 Tumour-Nodes-Metastasis staging system. van Oort IM; Witjes JA; Kok DE; Kiemeney LA; Hulsbergen-Van De Kaa CA BJU Int; 2008 Aug; 102(4):438-41. PubMed ID: 18336608 [TBL] [Abstract][Full Text] [Related]
12. Adjuvant radiotherapy after surgery for pathologically advanced prostate cancer. Van der Kwast TH; Collette L; Bolla M J Clin Oncol; 2007 Dec; 25(35):5671-2. PubMed ID: 18065746 [No Abstract] [Full Text] [Related]
13. Secondary cancer and relapse rates following radical prostatectomy for prostate-confined cancer. Wesley D; Cox HF J Insur Med; 2007; 39(4):242-50. PubMed ID: 18522141 [TBL] [Abstract][Full Text] [Related]
14. [The natural history of metastatic prostate cancer]. Lebret T; Méjean A Prog Urol; 2008 Nov; 18 Suppl 7():S327-31. PubMed ID: 19070811 [TBL] [Abstract][Full Text] [Related]
15. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer. Okegawa T; Nutahara K; Higashihara E J Urol; 2008 Oct; 180(4):1342-7. PubMed ID: 18707699 [TBL] [Abstract][Full Text] [Related]
16. [Diagnosis and treatment of prostate cancer]. Auvert J Ann Urol (Paris); 1999; 33(4):259-62. PubMed ID: 10510707 [No Abstract] [Full Text] [Related]
17. Metastatic disease of screen-detected prostate cancer : characteristics at diagnosis. Roemeling S; Kranse R; Vis AN; Gosselaar C; van der Kwast TH; Schröder FH Cancer; 2006 Dec; 107(12):2779-85. PubMed ID: 17109445 [TBL] [Abstract][Full Text] [Related]
18. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate. Sheridan T; Herawi M; Epstein JI; Illei PB Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190 [TBL] [Abstract][Full Text] [Related]
20. Comparative assessment of the 1992 and 2002 pathologic T3 substages for the prediction of biochemical recurrence after radical prostatectomy. Steuber T; Erbersdobler A; Graefen M; Haese A; Huland H; Karakiewicz PI Cancer; 2006 Feb; 106(4):775-82. PubMed ID: 16400637 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]